Your browser doesn't support javascript.
loading
Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.
Lee, Joyce V; Housley, Filomena; Yau, Christina; Nakagawa, Rachel; Winkler, Juliane; Anttila, Johanna M; Munne, Pauliina M; Savelius, Mariel; Houlahan, Kathleen E; Van de Mark, Daniel; Hemmati, Golzar; Hernandez, Grace A; Zhang, Yibing; Samson, Susan; Baas, Carole; Kok, Marleen; Esserman, Laura J; van 't Veer, Laura J; Rugo, Hope S; Curtis, Christina; Klefström, Juha; Matloubian, Mehrdad; Goga, Andrei.
Afiliação
  • Lee JV; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.
  • Housley F; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Yau C; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.
  • Nakagawa R; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Winkler J; Cancer and Developmental Therapeutics Program, Buck Institute for Research on Aging, Novato, California, USA.
  • Anttila JM; Departments of Pathology and Laboratory Medicine, University of California, San Francisco, California, USA.
  • Munne PM; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.
  • Savelius M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Houlahan KE; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.
  • Van de Mark D; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Hemmati G; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland.
  • Hernandez GA; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland.
  • Zhang Y; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland.
  • Samson S; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
  • Baas C; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.
  • Kok M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Esserman LJ; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.
  • van 't Veer LJ; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Rugo HS; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.
  • Curtis C; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Klefström J; Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.
  • Matloubian M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Goga A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
Nat Commun ; 13(1): 7140, 2022 Nov 21.
Article em En | MEDLINE | ID: mdl-36414627
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Commun Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Commun Ano de publicação: 2022 Tipo de documento: Article